Professor of Medicine Penn State Hershey Cancer Center
Hematology
Dr. Elliot M. Epner, MD
Elliot M. Epner practices Hematology. He went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care He has 12 awards "Grants Awarded", "Mentor, AACR Young Investigator Scholar Award, 2000", "National Cancer Institute GI Spore Award", "Louis J Kettel Faculty Mentor Award", "Arizona Elks Award", "McDonnell Fellow", "Medical Scientist Training Program Fellowship", "Alfred Steiner Dean's Day Award", "Upjohn Research Award", "Society of Blood Fellow's nite award", "Magna cum laude with honors in biology" and "New York State Regents Scholarship". Elliot Epner is a published physician. He published 44 publications, including: 'Description and targeted deletion of 5' hypersensitive site 5 and 6 of the mouse beta-globin locus control region.'
Publications
- Vorinostat Downregulates CD30 and Decreases Brentuximab Vedotin Efficacy in Human Lymphocytes.
- A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell Lymphoma; SWOG 0213.
- G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete enGraftment after allogeneic hematopoietic transplantation.
- Current approaches to epigenetic therapy for the treatment of mantle cell Lymphoma.
- Marginal zone Lymphoma: old, new, targeted, and epigenetic therapies.
- Flipping the cyclin D1 switch in mantle cell Lymphoma.
- Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell Lymphoma.
- Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple Myeloma.
- Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem Cell transplant patients.
- Cladribine: not just another purine Analogue?
- Transvection mediated by the translocated cyclin D1 locus in mantle cell Lymphoma.
- The epigenetics of mantle cell Lymphoma.
- Reduced-intensity conditioning followed by allogeneic hematopoietic Cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disord...
- Relapse risk in patients with malignant Diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
- Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell Lymphoma.
- Sox6 directly silences epsilon globin expression in definitive erythropoiesis.
- Targeted deletion of the chicken beta-globin regulatory elements reveals a cooperative gene silencing activity.
- Cyclin D1 activation in B-Cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal ...
- Replication initiation patterns in the beta-globin loci of totipotent and differentiated murine Cells: evidence for multiple initiation regions.
- Long-distance control of origin choice and replication timing in the human beta-globin locus are independent of the locus control region.
- An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: Analysis of the beta-globin locus contr...
- Efficient modification of human chromosomal alleles using recombination-proficient chicken/human microCell hybrids.
- Hematopoietic Cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
- What does the locus control region control?
- Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event Analyses of the multicenter phase 2 PINNACLE study.
- Hematopoietic Cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemogl...
- Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus.
- Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3.
- Reduced beta-globin gene expression in adult mice containing deletions of locus control region 5' HS-2 or 5' HS-3.
- The locus control region is necessary for gene expression in the human beta-globin locus but not the maintenance of an open chromatin structure in erythroid Cells.
- The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus.
- Description and targeted deletion of 5' hypersensitive site 5 and 6 of the mouse beta-globin locus control region.
- Role of polyadenylic acid in a deoxyribonucleic acid-membrane fraction exTracted from pneumococci.
- Induction of murine erythroLeukemia cells to differentiate: a model for the detection of new anti-tumor drugs.
- Induction of murine erythroLeukemia differentiation by actinomycin D.
- A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus.
- Replication and activation of the human beta-globin gene domain.
- Asynchronous DNA replication within the human beta-globin gene locus.
- Commitment to terminal differentiation and the Cell cycle.
- Replication of alpha and beta globin DNA sequences occurs during early S phase in murine erythroLeukemia cells.
- Commitment, DNA synthesis and gene expression in erythroLeukemia cells.
- Participation of the human beta-globin locus control region in initiation of DNA replication.
- Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region.
Schools
Columbia University College of Physicians And Surgeons
University Calif Irvine
University Wash
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Grants Awarded
- Mentor, AACR Young Investigator Scholar Award, 2000
- National Cancer Institute GI Spore Award
- Louis J Kettel Faculty Mentor Award
- Arizona Elk’s Award
- McDonnell Fellow
- Medical Scientist Training Program Fellowship
- Alfred Steiner Dean's Day Award
- Upjohn Research Award
- Society of Blood Fellow's nite award
- Magna cum laude with honors in biology
- New York State Regents Scholarship
Education
-
University of Washington -
University of California Irvine -
Columbia University -
Columbia University College of Physicians & Surgeons
Hospital
-
Penn State Milton S. Hershey Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Roland R. Alexander, MD |
|
|
Dr. Paul R. Grosh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur L. Williams II, MD |
|
|
Dr. Yang Liu, MD |
|
|
Dr. Prabha Jindal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Shashikant B. Patel, MB |